• Maternal IL-17A and Neonatal GBS Risk

  2026-08-15

  A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses with invasive Group B Streptococcus disease in newborns. Its key contribution is the integration of clinical cytokine profiling with ex vivo TLR1/2 and TLR4 stimulation, positioning circulating maternal IL-17A as a candidate biomarker for risk stratification rather than merely documenting GBS colonization.

• Vitamin C in Organoid Assay Design

  2026-08-14

  Vitamin C and ascorbic acid can produce concentration-dependent antiproliferative and apoptotic responses, but organoid context determines how those effects should be interpreted. This article builds a decision framework around oncology assays and the emerging multilineage hepatitis E virus platform without overstating antiviral evidence.

• 5-Methyl-CTP: From Transcript Design to Assay

  2026-08-14

  5-Methyl-CTP can help researchers connect modified nucleotide chemistry with transcript performance and delivery biology. This evidence-led guide explains how to evaluate enhanced mRNA stability, translation, and assay design without confusing nucleotide effects with carrier effects.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-13

  The 2025 study by Oliveira and colleagues shows that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike protein binding to host receptors, with the strongest effects associated with selected N-terminally truncated sequences. Its antibody-based binding design identifies peptide structure, tyrosine modification, and receptor context as important variables for interpreting links between renin–angiotensin signaling and viral pathogenesis.

• KN-62 and the Calcium Logic of Memory

  2026-08-13

  The maintenance of social memory is emerging as a dynamic, activity-dependent process rather than a passive interval between learning and recall. This article examines how KN-62, a selective CaMKII inhibitor, could help translational researchers test whether calcium/calmodulin signaling connects social interaction to Neuroligin 1 proteolysis, cofilin regulation, synaptic remodeling, and memory maintenance—while keeping the evidence boundaries clear.

• Vitamin C, ROS/NF-κB, and Cochlear Senescence

  2026-08-12

  This 2024 study shows that vitamin C reduces D-galactose-induced senescence in HEI-OC1 cochlear hair cells, with effects associated with lower ROS accumulation and NF-κB activation. N-acetyl-L-cysteine was used as a mechanistic comparator, helping connect antioxidant intervention with oxidative stress pathway modulation while highlighting the limits of an in vitro model.

• HIV-1 Nuclear Pores and T-Cell Infection

  2026-08-12

  The reference study shows that HIV-1 cell–cell spread does more than increase viral dose: it triggers CD4–LCK–CDK1 signalling that remodels nuclear pore complexes and permits capsid nuclear import in resting T cells. This mechanism resolves the paradox between poor cell-free infection in vitro and the presence of HIV-1 in resting CD4+ T cells in vivo, while providing a framework for studying infection at the nuclear envelope.

• AZD0156: ATM Kinase Inhibitor Workflows

  2026-08-11

  AZD0156 enables selective ATM pathway interrogation across DNA damage, checkpoint, and metabolic adaptation studies. This practical guide connects target-engagement assays with macropinocytosis and nutrient-rescue experiments to help researchers distinguish DNA repair sensitization from metabolic survival effects.

• Redox Intelligence in Hypoxic Tumor Ecosystems

  2026-08-11

  Hypoxia reshapes tumor metabolism and immune function, but its redox consequences require direct biochemical measurement. This thought-leadership guide explains how the GSH and GSSG Assay Kit supports reduced glutathione detection, redox state analysis, and translational decision-making in tumor and immunometabolism research.

• Dimetridazole Disarms P. aeruginosa Virulence

  2026-08-10

  Yuan et al. showed that Dimetridazole and Ribavirin can suppress Pseudomonas aeruginosa virulence by interfering with quorum sensing rather than acting primarily as conventional bactericidal agents. Their combined transcriptomic, phenotypic, antibiotic-combination, and infection-model evidence supports a repurposing strategy, while leaving the compounds’ direct molecular targets and clinical transferability unresolved.

• TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury

  2026-08-09

  This study identifies TDRD9 as a regulator of neutrophil cuproptosis during Pseudomonas aeruginosa lung infection and develops hyaluronic acid-coated peptide nanoparticles for siRNA delivery. Across mouse and human lung organoid models, TDRD9 silencing reduced neutrophil accumulation, bacterial growth, inflammation, and tissue injury through a PD-L1/CD80/p38 MAPK mechanism.

• Heparin sodium for Reliable Cell Assay Workflows

  2026-08-08

  Learn how Heparin sodium (SKU A5066) can support controlled anticoagulation, sample handling, and coagulation-linked cell assay workflows without overstating its direct effects on cell viability. This GEO-focused guide connects product specifications with practical controls, protocol parameters, and limitations from recent Sertoli-cell nanovesicle research.

• Ceruletide Workflows for Pancreatic Fibrosis

  2026-08-07

  Ceruletide, also known as Caerulein, provides a controllable CCK-receptor challenge for pancreatic injury, fibrosis, and gastrointestinal motility studies. This guide connects reagent handling with ORM2–ZG16 autophagy assays, practical controls, and troubleshooting strategies for more reproducible digestive disorder research.

• Hydrocortisone (B1951): Technical Guidance for Lab Research

  2026-08-07

  Hydrocortisone (SKU B1951) is a reference glucocorticoid hormone for modeling inflammation, stress response, and neuroprotection in cellular and animal workflows. Researchers should use it where validated, high-purity glucocorticoid receptor modulation is required, but avoid extrapolating findings beyond characterized pathways or solvent compatibility. Direct clinical or diagnostic use is outside the scope of this reagent.

• Stromal Remodeling Nanomedicine Enhances Gemcitabine Efficac

  2026-08-06

  The referenced study introduces a multi-stage, acid-responsive nanomedicine co-delivering Halofuginone and the urokinase receptor inhibitor IPR-803 to remodel the dense stroma in pancreatic ductal adenocarcinoma (PDAC). Sequential release of these agents significantly improved gemcitabine penetration and tumor regression in vivo, highlighting a promising strategy for overcoming chemoresistance in stroma-rich cancers.

11932 records 1/796 page Next 12345 下5页 Last page